Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 9
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP23F3963 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-05-17 | 2023-05-23 | 325412 | 8509895957!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3958 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-05-17 | 2023-05-23 | 325412 | 8509895533!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3378 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-04-19 | 2023-04-25 | 325412 | 8509839676!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3376 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-04-19 | 2023-04-25 | 325412 | 8509839671!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3372 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-04-19 | 2023-04-25 | 325412 | 8509839397!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2845 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-03-22 | 2023-03-28 | 325412 | 8509779035!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2822 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-03-22 | 2023-03-28 | 325412 | 8509778698!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1528 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-01-18 | 2023-01-24 | 325412 | 8509645246!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1526 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $458.09K | 2023-01-18 | 2023-01-24 | 325412 | 8509645241!ADENOVIRUS TYPE 4 A |
| SPE2DP23F0891 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-12-06 | 2022-12-20 | 325412 | 8509568683!ADENOVIRUS TYPE 4 A |
| SPE2DP23F0886 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-12-06 | 2022-12-20 | 325412 | 8509567963!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7356 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-09-13 | 2022-09-20 | 325412 | 8509383503!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6738 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-08-18 | 2022-08-30 | 325412 | 8509324050!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6109 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-07-18 | 2022-07-26 | 325412 | 8509243135!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6106 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-07-18 | 2022-07-26 | 325412 | 8509242748!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5160 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-06-14 | 2022-06-28 | 325412 | 8509165216!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5149 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-06-14 | 2022-06-28 | 325412 | 8509164636!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4653 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-05-17 | 2022-05-24 | 325412 | 8509105231!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4086 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-04-19 | 2022-04-26 | 325412 | 8509037359!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4078 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-04-19 | 2022-04-26 | 325412 | 8509034797!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3534 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-03-22 | 2022-03-29 | 325412 | 8508961292!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2573 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-02-10 | 2022-03-01 | 325412 | 8508862589!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2572 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-02-10 | 2022-03-01 | 325412 | 8508862586!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2571 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-02-10 | 2022-03-01 | 325412 | 8508862584!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2120 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-01-18 | 2022-01-25 | 325412 | 8508811985!ADENOVIRUS TYPE 4 A |